PCP
WST icon

Proficio Capital Partners’s West Pharmaceutical WST Stock Holding History

Proficio Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-190
Closed -$24K – 1560
2019
Q2 		$24K Buy
190
+8
+4% +$944 0.01% 623
2019
Q1 		$20K Hold
182
– – 0.01% 655
2018
Q4 		$18K Hold
182
– – 0.01% 579
2018
Q3 		$22K Buy
182
+8
+5% +$897 0.01% 570
2018
Q2 		$17K Buy
174
+9
+5% +$828 0.01% 657
2018
Q1 		$15K Hold
165
– – ﹤0.01% 687
2017
Q4 		$16K Sell
165
-9
-5% -$882 0.01% 658
2017
Q3 		$17K Sell
174
-18
-9% -$1.63K 0.01% 642
2017
Q2 		$17K Sell
192
-8
-4% -$736 0.01% 658
2017
Q1 		$19K Buy
200
+171
+590% +$14.3K 0.01% 637
2016
Q4 		$2K Buy
+29
New +$2.28K ﹤0.01% 949

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Proficio Capital Partners's WST Position: Q3 2019 in Review

Proficio Capital Partners sold out of West Pharmaceutical (WST) in Q3 2019, closing a stake of 190 shares — an estimated $24K sold.

Proficio Capital Partners first reported a position in WST in Q4 2016 and held it in 11 quarters. The position peaked at $24K in Q2 2019. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • Proficio Capital Partners reported no remaining West Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 190 West Pharmaceutical shares in Q3 2019, an estimated $24K.
  • Proficio Capital Partners first reported a position in West Pharmaceutical in Q4 2016 and held it in 11 quarters.
  • Proficio Capital Partners's West Pharmaceutical position peaked at $24K in Q2 2019.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.